A detailed history of Hancock Whitney Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 37,110 shares of MRK stock, worth $3.64 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
37,110
Previous 38,983 4.8%
Holding current value
$3.64 Million
Previous $4.83 Million 12.68%
% of portfolio
0.14%
Previous 0.17%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $208,183 - $241,560
-1,873 Reduced 4.8%
37,110 $4.21 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $1,733 - $1,861
-14 Reduced 0.04%
38,983 $4.83 Million
Q1 2024

May 16, 2024

BUY
$113.24 - $131.95 $447,298 - $521,202
3,950 Added 11.27%
38,997 $5.15 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $164,595 - $179,119
-1,643 Reduced 4.48%
35,047 $3.82 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $190,972 - $212,082
-1,855 Reduced 4.81%
36,690 $3.78 Million
Q2 2023

Nov 13, 2023

BUY
$108.61 - $118.38 $195,498 - $213,084
1,800 Added 4.9%
38,545 $4.45 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $195,498 - $213,084
1,800 Added 4.9%
38,545 $4.45 Million
Q1 2023

Nov 13, 2023

BUY
$102.94 - $114.86 $173,042 - $193,079
1,681 Added 4.79%
36,745 $3.91 Million
Q1 2023

May 16, 2023

BUY
$102.94 - $114.86 $173,042 - $193,079
1,681 Added 4.79%
36,745 $3.91 Million
Q4 2022

Nov 13, 2023

SELL
$87.44 - $112.11 $304,378 - $390,254
-3,481 Reduced 9.03%
35,064 $3.89 Million
Q4 2022

Feb 03, 2023

SELL
$87.44 - $112.11 $46,518 - $59,642
-532 Reduced 1.49%
35,064 $3.89 Million
Q3 2022

Oct 26, 2022

BUY
$84.53 - $94.96 $59,086 - $66,377
699 Added 2.0%
35,596 $3.07 Million
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $55,687 - $63,124
-667 Reduced 1.88%
34,897 $3.18 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $80,272 - $89,980
-1,092 Reduced 2.98%
35,564 $2.92 Million
Q4 2021

Jan 25, 2022

BUY
$72.28 - $90.54 $16,046 - $20,099
222 Added 0.61%
36,656 $2.81 Million
Q3 2021

Nov 04, 2021

SELL
$71.68 - $78.83 $174,540 - $191,951
-2,435 Reduced 6.26%
36,434 $2.74 Million
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $45,490 - $50,317
-647 Reduced 1.64%
38,869 $3.02 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $545,233 - $642,228
-7,918 Reduced 16.69%
39,516 $3.05 Million
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $141,171 - $156,671
-1,967 Reduced 3.98%
47,434 $3.88 Million
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $9,293 - $10,534
-127 Reduced 0.26%
49,401 $4.1 Million
Q2 2020

Jul 30, 2020

BUY
$70.42 - $80.13 $2,887 - $3,285
41 Added 0.08%
49,528 $3.83 Million
Q1 2020

May 08, 2020

BUY
$63.36 - $87.82 $455,938 - $631,952
7,196 Added 17.02%
49,487 $3.81 Million
Q4 2019

Feb 06, 2020

SELL
$77.58 - $87.54 $94,259 - $106,361
-1,215 Reduced 2.79%
42,291 $3.85 Million
Q3 2019

Oct 29, 2019

SELL
$76.08 - $82.93 $63,450 - $69,163
-834 Reduced 1.88%
43,506 $3.66 Million
Q2 2019

Aug 29, 2019

SELL
$69.84 - $81.59 $326,571 - $381,514
-4,676 Reduced 9.54%
44,340 $3.72 Million
Q1 2019

May 13, 2019

SELL
$69.58 - $79.36 $29,988 - $34,204
-431 Reduced 0.87%
49,016 $4.08 Million
Q4 2018

Feb 15, 2019

BUY
$65.24 - $75.71 $596,880 - $692,670
9,149 Added 22.7%
49,447 $3.78 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $1.97 Million - $2.32 Million
34,154 Added 555.89%
40,298 $2.86 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $48,949 - $57,510
-963 Reduced 13.55%
6,144 $373,000
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $50,246 - $58,400
-986 Reduced 12.18%
7,107 $387,000
Q4 2017

Feb 12, 2018

SELL
$51.62 - $61.64 $847,910 - $1.01 Million
-16,426 Reduced 66.99%
8,093 $455,000
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $8,741 - $9,406
-149 Reduced 0.6%
24,519 $1.57 Million
Q2 2017

Aug 11, 2017

BUY
N/A
24,668
24,668 $1.58 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.